PUBLISHER: The Business Research Company | PRODUCT CODE: 1435312
PUBLISHER: The Business Research Company | PRODUCT CODE: 1435312
Cerebrospinal fluid management (CSF) devices and equipment play a crucial role in treating hydrocephalus, a condition characterized by the excessive accumulation of CSF within the brain.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
The cerebrospinal fluid (CSF) management devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cerebrospinal fluid (CSF) management devices and equipment market statistics, including cerebrospinal fluid (CSF) management devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid (CSF) management devices and equipment market share, detailed cerebrospinal fluid (CSF) management devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid (CSF) management devices and equipment industry. This cerebrospinal fluid (CSF) management devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cerebrospinal fluid management (csf) devices and equipment market size has grown strongly in recent years. It will grow from $1.1 billion in 2023 to $1.16 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth observed in the historical period can be attributed to the increasing incidence of neurological disorders, an aging population, heightened awareness and education, government initiatives and funding, rising healthcare expenditure, as well as collaborations and partnerships.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see marginal growth in the next few years. It will grow to $1.22 billion in 2028 at a compound annual growth rate (CAGR) of 1.4%. The anticipated growth in the forecast period can be attributed to the increasing geriatric population, global healthcare infrastructure development, rising awareness, and screening programs, expanding applications, as well as emerging markets and untapped regions. Key trends during the forecast period include continued technological innovations, advancements in technology, growing awareness and diagnosis rates, the regulatory landscape, and patient-centric approaches.
The anticipated rise in neurological disorders is set to drive the expansion of the cerebrospinal fluid (CSF) devices market. Neurological disorders, affecting the brain, nerves, and spinal cord, prompt the use of CSF devices for diagnosis, monitoring, and treatment. As per the Alzheimer's Association's 2023 Alzheimer's Disease Facts and Figures, the cost of Alzheimer's and related dementias is projected to reach $345 billion in 2023, with estimates of nearly $1 trillion by 2050. This surge in neurological disorders underscores the growth of the cerebrospinal fluid (CSF) devices market.
An increase in the number of brain surgeries contributes to the demand for cerebrospinal fluid (CSF) devices. These devices, crucial in treating traumatic brain injuries (TBI), particularly utilize shunts to drain accumulated cerebrospinal fluid. In the United States, TBI is a leading cause of death, with 1.5 to 2 million adults and children experiencing it annually. Given the prevalence of brain injuries, the CSF devices market is poised for continual growth.
A significant constraint on the cerebrospinal fluid (CSF) devices market is the high such as lihood of shunt failure or malfunction. Shunts are employed to manage Hydrocephalus, a condition involving the accumulation of excess cerebrospinal fluid (CSF) near the brain. Research published on the National Library of Medicine in 2021 revealed a 30% complication rate within 30 days of shunting procedures, with 58% requiring at least one revision. Trust issues arise due to the substantial shunt failure rate, leading patients to seek alternative treatments.
The latest trend in the cerebrospinal fluid devices market involves the implementation of new and improved sensors. This trend holds potential for boosting growth rates and enhancing diagnostic quality. Addressing the complexities of treating Hydrocephalus, high-precision devices with new sensors and telemetry devices are being explored. Northwestern University's Rogers research group has developed an advanced skin sensor that can reduce malfunctions and the need for brain surgeries. The sensor, utilizing body temperature readings, provides information on CSF leakage and offers distinct heat signatures indicating shunt functionality.
Major players in the cerebrospinal fluid (CSF) devices market are introducing innovative products to meet unmet needs, such as the ReFlow Mini Flusher device. Launched by Anuncia Medical Inc. in July 2023, this second-generation device aims to treat hydrocephalus. Its compact design, reduced size, and simplified operation make it a promising innovation in hydrocephalus treatment.
While the US Food and Drug Administration (FDA) classifies CSF devices as class II devices, regulatory compliance involves a stringent protocol. This includes addressing potential health risks, submitting a cover sheet describing the device, providing a summary report, and ensuring biocompatibility and appropriate labeling. Adhering to these regulatory guidelines may extend the product release timeline and increase overall development costs, impacting the market.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market report are Biometrix Healthcare Pvt. Ltd., Delta Surgical Limited, Medtronic PLC, Stryker Corporation, B. Braun, DePuy Synthes, Olympus Corporation, Nitto Denko Corporation, Terumo Corporation, Mindray Medical International Limited, Mettler-Toledo International Inc., IMI Norgren Ltd., Maquet Getinge Group AB, Karl Storz GmbH & Co. KG, Smiths Medical Inc., Elekta AB, Integra LifeSciences Holdings Corporation, Brainlab AG, Penumbra Inc., Leica Biosystems Inc., Danobat S. Coop., Fujifilm Medical Systems USA Inc., Natus Medical Incorporated, G. Surgiwear Ltd., Sophysa USA Inc., Moller Medical GmbH, Wellong Instruments Co. Ltd., Argi Grup, Spiegelberg GmbH & Co. KG, BeckerSmith Medical Inc., Dispomedica GmbH
North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2023. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cerebrospinal Fluid Management (CSF) Devices And Equipment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cerebrospinal fluid management (csf) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cerebrospinal fluid management (csf) devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cerebrospinal fluid management (csf) devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.